1143.20
-14.70
(-1.27%)
374.8K
NSE+BSE Volume
NSE 13 Feb, 2026 10:37 AM (IST)
Analyst Buy
Axis Direct retains a 'Buy' call on Aurobindo Pharma, expects a revenue CAGR of 16.5% over FY26-28
See details